Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.

Pennington KL, DeAngelis MM.

Eye Vis (Lond). 2016 Dec 22;3:34. doi: 10.1186/s40662-016-0063-5. Review.

2.

Does the use of acetylsalicylic acid have an influence on our vision?

Michalska-Małecka K, Regucka A, Śpiewak D, Sosnowska-Pońska M, Niewiem A.

Clin Interv Aging. 2016 Nov 3;11:1567-1574. Review.

3.

The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9.

Al-Holou SN, Tucker WR, Agrón E, Clemons TE, Cukras C, Ferris FL 3rd, Chew EY; Age-Related Eye Disease Study 2 Research Group..

Ophthalmology. 2015 Dec;122(12):2490-6. doi: 10.1016/j.ophtha.2015.08.028.

4.

Association between statin use and uveitis: results from the Pacific Ocular Inflammation study.

Borkar DS, Tham VM, Shen E, Parker JV, Uchida A, Vinoya AC, Acharya NR.

Am J Ophthalmol. 2015 Apr;159(4):707-13. doi: 10.1016/j.ajo.2015.01.009.

5.

Elevated high-density lipoprotein cholesterol and age-related macular degeneration: the Alienor study.

Cougnard-Grégoire A, Delyfer MN, Korobelnik JF, Rougier MB, Le Goff M, Dartigues JF, Barberger-Gateau P, Delcourt C.

PLoS One. 2014 Mar 7;9(3):e90973. doi: 10.1371/journal.pone.0090973.

6.

Aspirin and age related macular degeneration; the possible relationship.

Wu Y, Zhu W, Li YH, Yu J.

Med Hypothesis Discov Innov Ophthalmol. 2013 Fall;2(3):59-68. Review.

7.

Age-related macular degeneration and protective effect of HMG Co-A reductase inhibitors (statins): results from the National Health and Nutrition Examination Survey 2005-2008.

Barbosa DT, Mendes TS, Cíntron-Colon HR, Wang SY, Bhisitkul RB, Singh K, Lin SC.

Eye (Lond). 2014 Apr;28(4):472-80. doi: 10.1038/eye.2014.8.

8.

Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration.

Guymer RH, Baird PN, Varsamidis M, Busija L, Dimitrov PN, Aung KZ, Makeyeva GA, Richardson AJ, Lim L, Robman LD.

PLoS One. 2013 Dec 31;8(12):e83759. doi: 10.1371/journal.pone.0083759.

9.

Topical nonsteroidal anti-inflammatory drugs for macular edema.

Russo A, Costagliola C, Delcassi L, Parmeggiani F, Romano MR, Dell'Omo R, Semeraro F.

Mediators Inflamm. 2013;2013:476525. doi: 10.1155/2013/476525. Review.

10.

Aspirin use and risk of age-related macular degeneration: a meta-analysis.

Zhu W, Wu Y, Xu D, Li YH, Jun B, Zhang XL, Wang F, Yu J.

PLoS One. 2013;8(3):e58821. doi: 10.1371/journal.pone.0058821.

11.

Statin use and ocular inflammatory disease risk.

Yunker JJ, McGwin G Jr, Read RW.

J Ophthalmic Inflamm Infect. 2013 Jan 11;3(1):8. doi: 10.1186/1869-5760-3-8.

12.

Nonsteroidal anti-inflammatory drugs for retinal disease.

Schoenberger SD, Kim SJ.

Int J Inflam. 2013;2013:281981. doi: 10.1155/2013/281981.

13.

Role of statins in the development and progression of age-related macular degeneration.

VanderBeek BL, Zacks DN, Talwar N, Nan B, Stein JD.

Retina. 2013 Feb;33(2):414-22. doi: 10.1097/IAE.0b013e318276e0cf.

14.

Identifying subtypes of patients with neovascular age-related macular degeneration by genotypic and cardiovascular risk characteristics.

Feehan M, Hartman J, Durante R, Morrison MA, Miller JW, Kim IK, DeAngelis MM.

BMC Med Genet. 2011 Jun 17;12:83. doi: 10.1186/1471-2350-12-83.

15.

Pleiotropic effects of the HMG-CoA reductase inhibitors.

Mihos CG, Santana O.

Int J Gen Med. 2011 Apr 4;4:261-71. doi: 10.2147/IJGM.S16779.

16.

Reduced choroidal neovascular membrane formation in cyclooxygenase-2 null mice.

Rezaei KA, Toma HS, Cai J, Penn JS, Sternberg P, Kim SJ.

Invest Ophthalmol Vis Sci. 2011 Feb 3;52(2):701-7. doi: 10.1167/iovs.10-6319.

17.
18.

Ketorolac inhibits choroidal neovascularization by suppression of retinal VEGF.

Kim SJ, Toma HS, Barnett JM, Penn JS.

Exp Eye Res. 2010 Oct;91(4):537-43. doi: 10.1016/j.exer.2010.07.011.

19.

Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial.

Maguire MG, Ying GS, McCannel CA, Liu C, Dai Y; Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group..

Ophthalmology. 2009 Dec;116(12):2381-5. doi: 10.1016/j.ophtha.2009.06.055.

20.

Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women.

Christen WG, Glynn RJ, Chew EY, Buring JE.

Ophthalmology. 2009 Dec;116(12):2386-92. doi: 10.1016/j.ophtha.2009.05.031.

Supplemental Content

Support Center